Categories
Can using a CGM help people with type 2 diabetes who don't use insulin pumps? Tomas Walker is Dexcom's Director of Clinical Projects. He shares the results of their new DIaMonD study (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes). Of course we also cover issues relevant to the type 1 community; Stacey asks about CGM use and Medicare coverage, possible changes to the Dexcom adhesive, and closed loop systems.
In our Community Connection this week, blogger Mindy Bartleson says sharing only the positive side of diabetes had a price. After going through some serious burnout, she wants to help others by sharing an honest look at growing up with chronic condition and mental illness. Mindy has a new book and is crowdfunding to publish (click to learn more and help).
Mindy also talks about the untethered or POLI method (pumper on long acting insulin) where she uses both a long-acting injection and her insulin pump.
New segment this week, called Shoptalk! Every diabetes convention has a big vendor floor where exhibitors show off the latest and greatest and educate consumers about their products or business. Stacey interviewed all 50 exhibitors(!) from the Friends for Life Conference and we'll be sharing those stories in the next few months. This week, learn about The Barton Center from associate director Lindsey Charest.
-----
4:00 Stacey shares an amazing letter from a listener in Japan who says the podcast helped through the "despair" of diagnosis
13:00 Interview with Tomas Walker
31:30 Interview with Mindy Bartleson
50:00 Shoptalk with The Barton Center
-----
Get our App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Sign up for our newsletter here
As always, thanks for listening!!
Lots of news from Dexcom recently! Stacey talks with retired Chief Technical Officer Jorge Valdes about the Apple Watch announcement and much more. (This interview took place just before the FDA approved Dexcom G5 for Android, but that news is covered in the episode).
Dexcom/Android info & compatible devices
Stacey also talks about the news that Beyond Type 1 is taking over Diabetes Hands Foundation's TuDiabetes.org and EsTuDiabetes.org
Stacey shares her personal connection to DHF and mentions this Big Blue Test video that she and her son made a few years ago.
Jason Gensler has the unique experience of being one of the longest users of one of the newest insulin pumps. He started in a pivotal trial of the Medtronic 670G two years ago and has been allowed to keep using it ever since. Jason shares his misgivings about going back to Medtronic; he had a bad experience with a previous pump and sensor. He also talks about why he feels this system is revolutionary and has given him a new way of looking at managing T1D.
This interview is the first we're sharing that was not conducted by Stacey. Jason is interviewed by Weston Nordren, Vice President of the Nightscout Foundation and Community Outreach for the Foundation. It was originally presented as a video (you can watch here)
Note: Jason Gensler does NOT work for Medtronic and is not compensated by them. He did not pay for the pump/sensor system as he received it as part of a clinical trial.
This week, Ed Damiano talks about his Bionic Pancreas project. Using a pump called the iLet and a Dexcom CGM, the only information the Bionic Pancreas needs is the user's body weight. It adapts to you, no need to figure out insulin to carb ratios or correction factors. The iLet will eventually come to market using both insulin and glucagon, but the first version will be insulin-only.
Stacey & Ed talk about the long journey to get to this point, why he had to start a brand new kind of company (Beta Bionics) to help bring the iLet to market and just when he expects it to be available.
Stacey also shares some of what she learned at the recent HealthEVoices Conference and talks about the milestone of this episode: It's the 100th regularly scheduled show for Diabetes Connections!
Anthony Hightower has used Afrezza for the past two years. He credits it (along with a Toujeo, a newer basal insuin) with completely changing his T1D management. In addition to excellent numbers, Anthony shares what else Afrezza has to offer. He explains, he liked it so much, he went to work for Mannkind, the company that makes Afrezza. He and Stacey also talk about the challenges Anthony faced since his diagnosis as a teenager. He admits he spent 20 years trying to avoid thinking about diabetes and credits the online community & the Diabetes Unconference with saving his life.
Stacey also shares what those little "clips" are that come with some pump insets. Her family learned the hard way at the beach a while back! She shares how her husband McGyver'd a solution when they'd left the clips at home.
And, find out how to contribute to our 100th episode coming up soon!
Tom Brobson is JDRF's National Director of Research Investment Opportunities. He was diagnosed with type 1 as an adult and has been involved personally in many artificial pancreas trials, the first of which had him hooked up to a computer in the hospital and not allowed to get up or go anywhere without a healthcare professional by his side. Of course, since then, the trials have included trials with equipment as small as a pump, CGM & smart phone.
Stacey recorded Tom as he gave a presentation at a local JDRF walk kickoff event. He talks about stem cell research, the artificial pancreas project and other advances in diabetes technology. He also talks about approvals and access.
In this episode, Stacey also talks about coughing for pain relief during shots and insertions. Really! We also share the adventures of people with T1D in the Arctic and in Alaska as this episode is released.
This week: OpenAPS, Looping, Happ - a bunch of weird sounding terms that are changing the way many manage diabetes. Tim Street has lived with type 1 for 28 years, he writes a blog called Diabettech. Tim talks about the DIY systems out there right now (he's tried almost all of them) and about all the new choices for people with diabetes available now an in the next few years. Lots of conversation in this show about the “art of the possible."
It's also Diabetes Podcast Week! This is the second year of Stacey's campaign to bring together podcasters and video bloggers to benefit Spare a Rose, Save a Child. Diabetes in developing countries can be a death sentence. This Valentine’s day, considering donating the cost of just one rose. That can keep a child with type 1 alive for a month. A dozen roses? That cost can cover a year. Spare a Rose benefits Life for a Child, an International Diabetes Federation Program.
This week, a conversation with Dexcom’s Chief Technical officer Jorge Valdes. Stacey talks with him about challenges and advances in 2016 and they look ahead to what's in the works for next year. Valdes shares what the FDA is currently considering and may approve for 2017, updates us on customer service issues and reacts to Medtronic's hybrid loop system coming out in the spring.
This is our last episode of 2016; there will be no new show released next week. Please check out our archives or search for your favorite topics or guests from the home page. And make sure you sign up for our newsletter (click here). If you didn't win our Sugar Linings Swag contest, we've got a coupon code going out before the end of the year.
Happy Holidays and a safe and happy New Year!!
This week, a big step forward for diabetes technology. The FDA recently approved the very first hybrid closed loop insulin system: the Medtronic MiniMed 670G. Medtronic's Chief Patient Officer Louis Dias and Social Media Manager Karrie Hawbaker talk to Stacey about what this product is, what it isn’t, access to it and what comes next.
Our Community Connection this week features a unique fundraiser, The Elbow Bump Challenge. Find out how 9-year-old Logan hopes to help out his favorite conference, Children with Diabetes, Friends For Life.
And Stacey talks about the Joslin Medalist Study for people living with type 1 for more than 25 years.
Important information this week about Glucagon, emergency treatment for severe low blood sugar. Stacey talks to Julie Settles, the US Medical Lead for Glucagon at Lilly. We find out more about how Glucagon works, when to use it (and when not to) and what the company is working on to make the delivery easier.
Community Connection this week is with James Wedding who convinced an academic summer program to change their Glucagon emergency use policy.
Plus, learn about the Big Blue Test from Diabetes Hands Foundation.